Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research Units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Developing formulated recombinant thiaminase I enzyme therapy for the treatment of acute lympoblastic leukemia
Moscow, Jeffrey
(PI)
Pediatrics
Overview
Fingerprint
Grants and Contracts Details
Description
Research to develop recombinant thiaminase I enzyme for the treatment of ALL.
Status
Finished
Effective start/end date
1/1/11
→
12/31/11
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Enzyme
Pharmacology, Toxicology and Pharmaceutical Science
100%
Leukemia
Pharmacology, Toxicology and Pharmaceutical Science
50%